Luther King Capital Management (LKCM)’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.27M Buy
67,333
+749
+1% +$51.1K 0.02% 264
2026
Q1
$4.3M Buy
66,584
+97
+0.1% +$6.84K 0.02% 267
2025
Q4
$4.47M Buy
66,487
+247
+0.4% +$16.6K 0.02% 270
2025
Q3
$4.86M Hold
66,240
0.02% 252
2025
Q2
$3.45M Hold
66,240
0.02% 285
2025
Q1
$4.23M Buy
+66,240
New +$3.85M 0.02% 248

Other funds holding HALO

Luther King Capital Management (LKCM)'s HALO Position: Q2 2026 in Review

Luther King Capital Management (LKCM) increased its Halozyme (HALO) stake by 1.1% in Q2 2026, buying an estimated $51.1K and bringing the position to 67,333 shares worth $5.27M. The position accounts for 0.02% of the portfolio, ranked #264.

Luther King Capital Management (LKCM) first reported a position in HALO in Q1 2025 and has held it in 6 quarters since. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Luther King Capital Management (LKCM) held 67,333 shares of Halozyme worth $5.27M as of Q2 2026.
  • Luther King Capital Management (LKCM) bought 749 Halozyme shares in Q2 2026, an estimated $51.1K.
  • Halozyme made up 0.02% of Luther King Capital Management (LKCM)'s portfolio in Q2 2026, its #264 holding.
  • Luther King Capital Management (LKCM) first reported a position in Halozyme in Q1 2025 and has held it in 6 quarters since.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Luther King Capital Management (LKCM)'s 13F filing for Q2 2026, filed 10 Aug 2026.